Vaccine consent letter
Dear Sir,
With regard to medical interventions administered at your school.
I do not give consent for any medical prophylactic intervention to be administered to my child (name).......................... and I remove the right for Gillick consent to be obtained from my child and put anyone who coerces my child against my wishes on warning that they will be guilty of “battery and civil wrong of trespass” as outlined in the Griffith study of 2016 (reference below).
The 2016 Griffith study explains that “as children grow and develop in maturity, their views and wishes must be given greater weight and their development toward adulthood must be respected and promoted”. This transition into adulthood is termed “Gillick competence”. With regard to medical interventions the study quotes the “House of Lords in Gillick v West Norfolk and Wisbech AHA [1986]”, in which it was ruled that a Gillick competent child is one that has “sufficient maturity and intelligence to understand the nature and implications” of the treatment in question.
Gillick competence is further defined as:-
• • Maturity. That takes account of the child’s experiences and the child’s ability to manage influences on their decision making such as information, peer pressure, family pressure, fear and misgivings.
• • Intelligence. That takes account of the child’s understanding, ability to weigh risk and benefit, consideration of longer term factors such as effect on family life and on such things as schooling.
The study then goes on to explain “the degree of maturity and intelligence needed depends on the gravity of the decision” and explains that “decision making competence does not simply arrive with puberty; it depends on the maturity and intelligence of the child and the seriousness of the treatment decision to be made”. The study also says that the “assessment of Gillick competence requires an examination of how the child deals with the process of making a decision based on an analysis of the child’s ability to understand and assess risks” and it warns that “it is a high test of competence that is more difficult to satisfy the more complex the treatment and its outcomes become”. It explains that “sufficient time for the assessment must be allowed by the health professional who needs to be satisfied that a child has fully understood the nature and consequences of the proposed immunization and is mature enough to take account of broader health and social factors when making their decision”.
Finally, the study notes that “immunization is not compulsory in the UK so the courts cannot simply insist that children are vaccinated. Courts cannot treat the matter as a case of significant harm to a child that would warrant state intervention under the Children Act 1989”. I therefore contend that schools do not have this right either. Furthermore, the Merck handbook’s advice for immunisations by Porter, states on page 1306 that “Parents should give written consent for vaccination of their children” after the risks are fully disclosed and examined.
I do not believe the possible dangers and long term adverse effects are disclosed to parents, and children are unable to read the appropriate science studies to discover those dangers for themselves. The medical workers are not fully informed of the potential adverse effects nor of the lack of efficacy, and therefore are unable to convey the truth to any adult patient and definitely not to a child.
I have made references to studies that support my understanding of the dangers and lack of efficacy of prophylactics but, if you need me to elaborate in person, please make a mutually convenient appointment for me to attend your office. I believe you will agree, after reading the studies I have listed below, that the subject is beyond the scope of many adults to understand and definitely not in the grasp of a child or young adult who has not studies immunology to a considerable standard.
Please find attached a copy of the consent form I require to be completed before any medical prophylactic is administered. Please acknowledge receipt of this letter by return and acknowledge the understanding of my instructions herewith. Keep this communication in my child’s file so that any school staff member can access it and know my demands.
Yours sincerely
Your name
Vaccine consent form
CHILD’S NAME: -_________________________________
No vaccination or medical intervention should be given to my child without my express permission. Gillick consent may not be used by any person to coerce my child into accepting medical interventions against my will. I will treat all unsolicited PROPHYLACTIC medical procedures undertaken during school time as assault and will pursue the individual perpetrators, school and education governing bodies through the appropriate courts. If a vaccination is offered to my child conditions 1, 2, and 3 below should be met and this information should be sent to me for evaluation 1 month before the planned medical intervention. This includes administration by injections, nasal sprays, oral drops or any other delivery system.
1) That the booklet which is supplied is fully accurate both as to the safety and the efficacy of the vaccine.
2) That the doctor or nurse performing the vaccine, the health Authority, the manufacturer of the vaccine and the Department of health will accept full joint and several responsibility for any injury or neurological regression experienced by my child after the vaccine has been administered.
3) That, in the event of any such injury being caused, my child will receive full compensation, assessed in accordance with the normal principles of English Tort Law.
When I receive this form completed and signed by an appropriate Health Care representative I will consider your request further but you will only have permission to administer prophylactic medical procedures to my child when you receive my direct express consent in subsequent communication displaying my signature.
Date: _____________________________________________
Signed: ___________________________________________
Name printed: ______________________________________
Position within Health Department: ____________________
References:-
Agmon-Levin, N., Kivity, S., Szyper-Kravitz, M. and Shoenfeld, Y. (2009). Transverse myelitis and vaccines: a multi-analysis. Lupus, 18(13) 1198-1204.
Arumugham, V. (2015). Evidence that Food Proteins in Vaccines Cause the Development of Food Allergies and Its Implications for Vaccine Policy. J Dev Drugs, 4(137) 2.
Arumugham, V. (2017). Bioinformatics analysis links type 1 diabetes to vaccines contaminated with animal proteins and autoreactive T cells express skin homing receptors consistent with injected vaccines as causal agent.
Aucouturier, J., Ascarateil, S. and Dupuis, L. (2006). The use of oil adjuvants in therapeutic vaccines. Vaccine, 24, S44-S45.
Belyaeva, E.A., Sokolova, T.V., Emelyanova, L.V. and Zakharova, I.O., 2012. Mitochondrial electron transport chain in heavy metal-induced neurotoxicity: effects of cadmium, mercury, and copper. The Scientific World Journal, 2012.
Blaylock, R.L. (2008). The truth behind the vaccine cover-up. Medical Veritas, 5(1), 714-26.
Cave, S.F. (2008). The history of vaccinations in the light of the autism epidemic. Alternative Therapies in Health & Medicine, 14(6).
Chong, Y. and Ikematsu, H. (2017). Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants. Vaccine, 35(2) 255-263.
Davenport, F.M. (1961). Applied immunology of mineral oil adjuvants. Journal of Allergy and Clinical Immunology, 32(3), 177-189.
DeLong, G. (2018). A lowered probability of pregnancy in females in the USA aged 25–29 who received a human papillomavirus vaccine injection. Journal of Toxicology and Environmental Health, Part A, 81(14) 661-674.
Dhiman, R., Prakash, S., Sreenivas, V. and Puliyel, J. (2018). Correlation between Non-Polio Acute Flaccid Paralysis Rates with Pulse Polio Frequency in India. International journal of environmental research and public health, 15(8) 1755.
Eghafona, N.O., 1996. Immune responses following cocktails of inactivated measles vaccine and Arachis hypogaea L.(groundnut) or Cocos nucifera L.(coconut) oils adjuvant. Vaccine, 14(17-18), pp.1703-1706
Exley, C. (2019). An aluminium adjuvant in a vaccine is an acute exposure to aluminium. Journal of trace elements in medicine and biology: organ of the Society for Minerals and Trace Elements (GMS), 57, 57.
Gatti, A.M. and Montanari, S. (2017). New quality-control investigations on vaccines: micro-and nanocontamination. International Journal of Vaccines and Vaccination, 4(1) 00072.
Geier, D.A., King, P.G. and Geier, M.R. (2009). Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compounds. Toxicological & Environmental Chemistry, 91(4) 735-749
Greenland, K., Whelan, J., Fanoy, E., Borgert, M., Hulshof, K., Yap, K.B., Swaan, C., Donker, T., van Binnendijk, R., de Melker, H. and Hahné, S. (2012). Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine, 30(31) 4676-4680.
Griffith, R. (2016). What is Gillick competence?. Human vaccines & immunotherapeutics, 12(1) 244-247.
Gustafson, T.L., Lievens, A.W., Brunell, P.A., Moellenberg, R.G., Buttery, C.M. and Sehulster, L.M. (1987). Measles outbreak in a fully immunized secondary-school population. New England journal of medicine, 316(13) 771-774.
Hurwitz, E.L. and Morgenstern, H. (2000). Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. Journal of manipulative and physiological therapeutics, 23(2) 81-90.
Humphrey, M.L., Cole, M.P., Pendergrass, J.C. and Kiningham, K.K. (2005). Mitochondrial mediated thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH). Neurotoxicology, 26(3) 407-416.
Jacquez, J.A. (1987). A note on chain-binomial models of epidemic spread: what is wrong with the Reed-Frost formulation?. Mathematical Biosciences, 87(1) 73-82.
Mawson, A.R., Ray, B.D., Bhuiyan, A.R. and Jacob, B. (2017). Pilot comparative study on the health of vaccinated and unvaccinated 6-to 12-year-old US children. J. Transl. Sci, 3(3) 1-12.
Poling, J.S., Frye, R.E., Shoffner, J. and Zimmerman, A.W. (2006). Developmental regression and mitochondrial dysfunction in a child with autism. Journal of child neurology, 21(2) 170-172.
Porter, R. S., & Kaplan, J. L. (Eds.). (2011). The Merck manual of diagnosis and therapy. The Merck manual of diagnosis and therapy (19th ed.). Kenilworth, NJ, US: Merck Sharp & Dohme Corp..
Read, A.F., Baigent, S.J., Powers, C., Kgosana, L.B., Blackwell, L., Smith, L.P., Kennedy, D.A., Walkden-Brown, S.W. and Nair, V.K. (2015). Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biology, 13(7) e1002198.
Schonberger, L.B., Bregman, D.J., Sullivan-Bolyai, J.Z., Keenlyside, R.A., Ziegler, D.W., Retailliau, H.F., Eddins, D.L. and Bryan, J.A. (1979). Guillain-Barré syndrome following vaccination in the national influenza immunization program, United States, 1976–1977. American journal of epidemiology, 110(2) 105-123.
Schwartz, V.E. (1985). Unavoidably unsafe products: Clarifying the meaning and policy behind comment K. Wash. & Lee L. Rev., 42, p.1139.
Shaw, C.A. and Petrik, M.S. (2009). Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. Journal of inorganic biochemistry, 103(11) 1555-1562.
Stern, A., Te Yeh, M., Zinger, T., Smith, M., Wright, C., Ling, G., Nielsen, R., Macadam, A. and Andino, R. (2017). The evolutionary pathway to virulence of an RNA virus. Cell, 169(1) 35-46.
Tomljenovic, L. and Shaw, C.A. (2012). Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations. Lupus, 21(2) 223-230.
Vashisht, N. and Puliyel, J. (2012). Polio programme: let us declare victory and move on. Indian J Med Ethics, 9(2) 114-7.
Waaijenborg, S., Hahné, S.J., Mollema, L., Smits, G.P., Berbers, G.A., van der Klis, F.R., de Melker, H.E. and Wallinga, J. (2013). Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. The Journal of infectious diseases, 208(1) 10-16.
Woodhour, A.F., Metzgar, D.P., Stim, T.B., Tytell, A.A. and Hilleman, M.R. (1964). New metabolizable immunologic adjuvant for human use. I. Development and animal immune response. Proceedings of the Society for Experimental Biology and Medicine, 116(2), 516-523.